Clinical trial
Multicenter Retrospective Observational Study to Evaluate the Efficacy of Anti-Jak1 Inhibitors as Treatment for Patients With Aicardi-Goutières Syndrome
NCT06898372 is registered in ClinicalTrials.gov with IRCCS Fondazione Stella Maris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Retrospective Observational Study to Evaluate the Efficacy of Anti-Jak1 Inhibitors as Treatment for Patients With Aicardi-Goutières Syndrome
- Lead sponsor
- IRCCS Fondazione Stella Maris
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 7, 2024
- Completion date
- December 18, 2024
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aicardi-goutières syndrome (ags)